Altiscreen has secured CHF 150,000 from Venture Kick to develop a portable drug-testing solution capable of delivering results in three minutes, addressing urgent needs for reliable on-the-spot screening across various sectors.

Information on the Target

Altiscreen, a medtech startup founded in 2024 by Dr. Leonard Dumea, has secured CHF 150,000 from Venture Kick to advance the development of its portable drug-testing solution. The device is engineered to deliver accurate results within three minutes, making it highly suitable for roadside checks, workplace screening, and mobile healthcare teams requiring immediate and reliable information. This innovative approach addresses the significant challenges associated with current drug-testing solutions, which often necessitate prolonged laboratory processing and may compromise accuracy in real-world scenarios.

Altiscreen's technology leverages oral fluid, urine, or trace samples for the fast and precise detection of multiple substances. The implications of this capability extend across various domains, including healthcare, workplace safety, law enforcement, and event management, where prompt screening is paramount. With an ambitious plan to deploy several thousand drug-screening devices annually worldwide, Altiscreen seeks to enhance safety measures related to drug consumption, which has been rising steadily across the globe.

Industry Overview in Switzerland

Switzerland's medtech industry is renowned for its innovative research and high-quality standards, characterized by a well-established ecosystem comprising startups, established firms, and educat